Gikas Katsifis

1.4k total citations
34 papers, 831 citations indexed

About

Gikas Katsifis is a scholar working on Rheumatology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gikas Katsifis has authored 34 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 9 papers in Pathology and Forensic Medicine and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gikas Katsifis's work include Spondyloarthritis Studies and Treatments (9 papers), Systemic Sclerosis and Related Diseases (9 papers) and Viral Infections and Immunology Research (8 papers). Gikas Katsifis is often cited by papers focused on Spondyloarthritis Studies and Treatments (9 papers), Systemic Sclerosis and Related Diseases (9 papers) and Viral Infections and Immunology Research (8 papers). Gikas Katsifis collaborates with scholars based in Greece, United Kingdom and United States. Gikas Katsifis's co-authors include Niki M. Moutsopoulos, Sharon M. Wahl, Stanley R. Pillemer, Genovefa Kolovou, Sophie Mavrogeni, Λουκία Κουτσογεωργοπούλου, George Markousis‐Mavrogenis, Georgia Karabela, Athanasios G. Tzioufas and John P. A. Ioannidis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

Gikas Katsifis

33 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gikas Katsifis Greece 15 307 288 241 167 150 34 831
Kyriaki Boki Greece 21 204 0.7× 761 2.6× 347 1.4× 105 0.6× 158 1.1× 54 1.2k
G. Castellino Italy 17 133 0.4× 623 2.2× 343 1.4× 39 0.2× 185 1.2× 32 934
Rosario Foti Italy 16 80 0.3× 427 1.5× 183 0.8× 134 0.8× 133 0.9× 93 986
Inge Juul Sørensen Denmark 20 141 0.5× 826 2.9× 421 1.7× 49 0.3× 112 0.7× 63 1.4k
Pier Franca Gambari Italy 16 123 0.4× 782 2.7× 434 1.8× 113 0.7× 159 1.1× 28 1.2k
Kimihiro Suzuki Japan 16 84 0.3× 291 1.0× 244 1.0× 93 0.6× 101 0.7× 59 869
A. d’Ascanio Italy 18 102 0.3× 357 1.2× 143 0.6× 42 0.3× 192 1.3× 52 764
Nina Boulman Israel 17 50 0.2× 449 1.6× 234 1.0× 125 0.7× 223 1.5× 70 1.2k
Şenol Kobak Türkiye 15 314 1.0× 353 1.2× 119 0.5× 18 0.1× 91 0.6× 88 796
Goran Radunović Serbia 19 212 0.7× 392 1.4× 127 0.5× 32 0.2× 108 0.7× 48 846

Countries citing papers authored by Gikas Katsifis

Since Specialization
Citations

This map shows the geographic impact of Gikas Katsifis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gikas Katsifis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gikas Katsifis more than expected).

Fields of papers citing papers by Gikas Katsifis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gikas Katsifis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gikas Katsifis. The network helps show where Gikas Katsifis may publish in the future.

Co-authorship network of co-authors of Gikas Katsifis

This figure shows the co-authorship network connecting the top 25 collaborators of Gikas Katsifis. A scholar is included among the top collaborators of Gikas Katsifis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gikas Katsifis. Gikas Katsifis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Savvari, Paraskevi, Ioannis Skiadas, Stamatios A Papadakis, et al.. (2023). The impact of moderate to severe osteoarthritis on the physical performance and quality of life: a cross-sectional study in Greek patients (PONOS study). BMC Musculoskeletal Disorders. 24(1). 651–651. 4 indexed citations
3.
Savvari, Paraskevi, Ioannis Skiadas, Stamatios A Papadakis, et al.. (2023). Moderate to Severe Osteoarthritis: What is the Economic Burden for Patients and the Health Care System? Insights from the “PONOS” Study. Cartilage. 15(3). 268–277. 5 indexed citations
4.
5.
Katsifis, Gikas, Andreas Bounas, Panagiotis Georgiou, et al.. (2022). Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study. Mediterranean Journal of Rheumatology. 33(Suppl 1). 162–162. 1 indexed citations
6.
Athanassiou, Panagiotis, Andreas Bounas, Theodoros Dimitroulas, et al.. (2021). The effects of golimumab on work productivity and quality of life among work-active axial spondyloarthritis and psoriatic arthritis patients treated in the routine care in Greece: the ‘GO-UP’ study. Quality of Life Research. 31(5). 1385–1399. 1 indexed citations
7.
Katsifis, Gikas, et al.. (2021). Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis. Clinical and Experimental Rheumatology. 39(5). 1033–1042. 6 indexed citations
8.
Smolen, Josef S, Stefan Siebert, Т. В. Коротаева, et al.. (2021). Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results. Annals of the Rheumatic Diseases. 80(11). 1419–1428. 22 indexed citations
9.
Markousis‐Mavrogenis, George, Michael T. Nurmohamed, Λουκία Κουτσογεωργοπούλου, et al.. (2020). Current understanding and future perspectives of brain–heart–kidney axis in psoriatic arthritis. Rheumatology International. 40(9). 1361–1368. 1 indexed citations
10.
Baraliakos, Xenofon, Torsten Witte, Luc S. De Clerck, et al.. (2020). Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe. Lara D. Veeken. 60(1). 113–124. 4 indexed citations
11.
Markousis‐Mavrogenis, George, Λουκία Κουτσογεωργοπούλου, Theodoros Dimitroulas, et al.. (2020). Is There a Brain/Heart Interaction in Rheumatoid Arthritis and Seronegative Spondyloartropathies? A Combined Brain/Heart Magnetic Resonance Imaging Reveals the Answer. Current Rheumatology Reports. 22(8). 39–39. 6 indexed citations
12.
Markousis‐Mavrogenis, George, Vasiliki-Kalliopi Bournia, Stylianos Panopoulos, et al.. (2019). Cardiovascular Magnetic Resonance Identifies High-Risk Systemic Sclerosis Patients with Normal Echocardiograms and Provides Incremental Prognostic Value. Diagnostics. 9(4). 220–220. 28 indexed citations
13.
Mavrogeni, Sophie, George Markousis‐Mavrogenis, Λουκία Κουτσογεωργοπούλου, et al.. (2017). Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases. International Journal of Cardiology. 236. 151–156. 44 indexed citations
14.
Mavrogeni, Sophie, Λουκία Κουτσογεωργοπούλου, Georgia Karabela, et al.. (2017). Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. BMC Cardiovascular Disorders. 17(1). 187–187. 37 indexed citations
15.
Mavrogeni, Sophie, Georgia Karabela, Λουκία Κουτσογεωργοπούλου, et al.. (2016). Pseudo-infarction pattern in diffuse systemic sclerosis. Evaluation using cardiovascular magnetic resonance. International Journal of Cardiology. 214. 465–468. 14 indexed citations
16.
Mavrogeni, Sophie, Konstantinos Bratis, Λουκία Κουτσογεωργοπούλου, et al.. (2016). Myocardial perfusion in peripheral Raynaud's phenomenon. Evaluation using stress cardiovascular magnetic resonance. International Journal of Cardiology. 228. 444–448. 26 indexed citations
17.
Mavrogeni, Sophie, Georgia Karabela, Elias Gialafos, et al.. (2013). Cardiac Involvement in ANCA (+) and ANCA (-) Churg-Strauss Syndrome Evaluated by Cardiovascular Magnetic Resonance. Inflammation & Allergy - Drug Targets. 12(5). 322–327. 25 indexed citations
18.
Katsifis, Gikas, et al.. (2009). Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome Immunopathogenesis. American Journal Of Pathology. 175(3). 1167–1177. 248 indexed citations
19.
Katsifis, Gikas, Niki M. Moutsopoulos, & Sharon M. Wahl. (2007). T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology. Clinical Reviews in Allergy & Immunology. 32(3). 252–264. 88 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyriaki Boki Breakdown of academic impact, for papers by G. Castellino Breakdown of academic impact, for papers by Rosario Foti Breakdown of academic impact, for papers by Inge Juul Sørensen Breakdown of academic impact, for papers by Pier Franca Gambari Breakdown of academic impact, for papers by Kimihiro Suzuki Breakdown of academic impact, for papers by A. d’Ascanio Breakdown of academic impact, for papers by Nina Boulman Breakdown of academic impact, for papers by Şenol Kobak Breakdown of academic impact, for papers by Goran Radunović
Rankless by CCL
2026